Infection-related stillbirths

The Lancet

Volumn 375, Issue 9724, 2010, Pages 1482-1490

  Goldenbrg, R L ^a   McClure, E M ^b,c   Saleem, S ^d   Reddy, U M ^e  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c RTI INTERNATIONAL   (United States)

^d AGA KHAN UNIVERSITY   (Pakistan)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSECTICIDE; VIRUS DNA; VIRUS RNA;

ADVERSE OUTCOME; AFRICAN TRYPANOSOMIASIS; ANTHRAX; ANTIBODY RESPONSE; APLASTIC ANEMIA; BACTERIAL INFECTION; BED NET; BORRELIA BURGDORFERI; BORRELIA DUTTONNII; BORRELIA INFECTION; BORRELIA RECURRENTIS; BRUCELLOSIS; CHAGAS DISEASE; CHEMOPROPHYLAXIS; CHICKENPOX; CHILDHOOD DISEASE; CHORIOAMNIONITIS; CONGENITAL SYPHILIS; DENGUE; DENGUE VIRUS; DISEASE CARRIER; DOMESTIC ANIMAL; ERYTHEMA INFECTIOSUM; FETUS DEATH; FETUS HYDROPS; FOOD CONTAMINATION; FRANCISELLA TULARENSIS; HEART INJURY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A H1N1; INTRAUTERINE INFECTION; LEPTOSPIROSIS; LISTERIOSIS; LJUNGAN VIRUS; LYME DISEASE; LYMPHOCYTIC CHORIOMENINGITIS; MALARIA; MALARIA CONTROL; MEASLES; MOSQUITO; MUMPS; PARVOVIRUS; PLASMODIUM FALCIPARUM; POINT OF CARE TESTING; POLIOMYELITIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; Q FEVER; RASH; REVIEW; RISK ASSESSMENT; RISK REDUCTION; RUBELLA; SCREENING; SEROLOGY; SICKLE CELL ANEMIA; STILLBIRTH; STREPTOCOCCUS; STREPTOCOCCUS PORCINUS; TICK; TICK BORNE DISEASE; TOXOPLASMOSIS; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI; TSETSE FLY; TULAREMIA; VACCINATION; VIRUS; VIRUS INFECTION; WATER CONTAMINATION; ARTICLE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FEMALE; MICROBIOLOGY; NEWBORN; PARASITOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; VIROLOGY;

DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; STILLBIRTH;

EID: 77952300089     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61712-8     Document Type: Review

References (107)

1. Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: delivering estimates in 190 countries. Lancet 2006;367:1487-94.
2. Lawn J, Shibuya K, Stein C. No cry at birth: global estimates of intrapartum stillbirths and intrapartum-related neonatal deaths 2005. Bull World Health Organ 2005;83:409-17.
3. McClure EM, Phiri M, Goldenberg RL. Stillbirth in developing countries: a review of the literature. Int J Gynaecol Obstet 2006;94:82-90.
4. Rawlinson WD, Hall B, Jones CA, et al. Viruses and other infections in stillbirth: what is the evidence and what should we be doing? Pathology 2008;40:149-60.
5. Gibbs RS. The origins of stillbirth: infectious diseases. Semin Perinatol 2002;26:75-78.
6. Goldenberg RL, Thompson C. The infectious origin of stillbirth. Am J Obstet Gynecol 2003;189:861-73.
7. Di Mario S, Say L, Lincetto O. Risk factors for stillbirth in developing countries: a systematic review of the literature. Sex Transm Dis 2007;34 (suppl): S11-21.
8. Fretts R. Etiology and prevention of stillbirths. Am J Obstet Gynecol 2005;193:1923-35.
9. Cnattingius S, Stephansson O. The epidemiology of stillbirth. Semin Perinatol 2002;26:25-30.
10. Copper RL, Goldenberg RL, DuBard MB, Davis RO. Risk factors for fetal death in white, black, and Hispanic women. Obstet Gynecol 1994;84:490-95.
11. Korteweg FJ, Gordijn SJ, Timmer A, Holm JP, Ravise JM, Erwich JJHM. A placental cause of intra-uterine fetal death depends on the perinatal mortality classifi cation system used. Placenta 2008;29:71-80.
12. Nuovo GJ, Cooper LD, Bartholomew D. Histologic, infectious, and molecular correlates of idiopathic spontaneous abortion and perinatal mortality. Diagn Mol Pathol 2005;14:152-58.
13. Hardy JB, Azarowicz EN, Mannini A, Medaris DN Jr, Cooke RE. The eff ect of Asian infl uenza on the outcome of pregnancy, Baltimore, 1957-1958. Am J Public Health Nations Health 1961;51:1182-88.
14. Horn P. Poliomyelitis in pregnancy: a twenty-year report from Los Angeles County, California. Obstet Gynecol 1955;6:121-37.
15. Schwarz NG, Adegnika AA, Breitling LP, et al. Placental malaria increases malaria risk in the fi rst 30 months of life. Clin Infect Dis 2008;47:1017-25.
16. Blanc W. Pathways of fetal and early neonatal infection. J Pediatr 1961;59:473-96.
17. Cooper LZ, Alford CA. Rubella. In: Remington JS, Klein JO, Baker C, Wilson CB, eds. Infectious diseases of the fetus and newborn infant. Philadelphia, PA: WB Saunders, 2006:893-926.
18. Goldenberg RL, Hauth JC, Andrews W W. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-07.
19. Niklasson B, Samsioe A, Papadogiannakis N, et al. Association of zoonotic Ljungan virus with intrauterine fetal deaths. Birzvth Defects Res A Clin Mol Teratol 2007;79:488-93.
20. Martin C, Fermeauz V, Eyraud JL, Aubard Y. Streptococcus porcinus as a cause of spontaneous preterm human stillbirth. J Clin Microbiol 2004;42:4396-98.
21. Lumbiganon P, Piaggio G, Villar J, et al. The epidemiology of syphilis in pregnancy. Int J STD AIDS 2002;13:486-94.
22. Genc M, Ledger WJ. Syphilis in pregnancy. Sex Transm Infect 2000;76:73-79.
23. Congenital syphilis-United States, 2000. MMWR Morb Mortal Wkly Rep 2001;50:573-77.
24. Folgosa E, Osman NB, Gonzalez C, Hagerstrand I, Bergstrom S, Ljungh A. Syphilis seroprevalence among pregnant women and its role as a risk factor for stillbirth in Maputo, Mozambique. Genitourin Med 1996;72:339-42.
25. Potter D, Goldenberg RL, Read JS, et al. Correlates of syphilis seroreactivity among pregnant women: The HIVNET 024 trial in Malawi, Tanzania and Zambia. Sex Transm Dis 2006;33:604-09.
26. Schmid GP, Stoner BP, Hawkes S, Broutet N. The need and plan for global elimination of congenital syphilis. Sex Transm Dis 2007;34 (suppl): S5-10.
27. Schmid GP. Economic and programmatic aspects ofcongenital syphilis elimination. Bull World Health Organ 2004;82:402-09.
28. Sheffield JS, Sanchez PJ, Wendel GD, et al. Placental histopathology of congenital syphilis. Obstet Gynecol 2002;100:126-33.
29. Watson-Jones D, Changalucha J, Gumadoka B, et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 2002;186:940-47.
30. Salakhov E, Tikhonova L, Southwick K, Shakarishvili A, Ryan C, Hillis C. Congenital syphilis in Russia: the value of counting epidemiologic cases and clinical cases. Sex Transm Dis 2004;31:127-32.
31. Sethi S, Sharma K, Dhaliwal LK, Banga SS, Sharma M. Declining trends in syphilis prevalence among antenatal women in northern India: a 10-year analysis from a tertiary healthcare centre. Sex Transm Infect 2007;83:592.
32. Vásquez-Manzanilla O, Dickson-Gonzalez SM, Salas JG, Rodriguez-Morales AJ, Arria M. Congenital syphilis in Valera, Venezuela. J Trop Pediatr 2007;53:274-77.
33. Watson-Jones D, Weiss HA, Changalucha JM, et al. Adverse birth outcomes in United Republic of Tanzania-impact and prevention of maternal risk factors. Bull World Health Organ 2007;85:9-17.
34. Chi BH, Wang L, Read JS, et al. Stillbirth in sub-Saharan Africa. Obstet Gynecol 2007;110:989-97.
35. Rydzak CE, Goldie SJ. Cost-effectiveness of rapid point-of-care prenatal syphilis screening in sub-Saharan Africa. Sex Transm Dis 2008;35:775-84.
36. Hossain M, Broutet N, Hawkes S. The elimination of congenital syphilis: a comparison of the proposed World Health Organization Action Plan for the elimination of congenital syphilis with existing national maternal and congenital syphilis policies. Sex Transm Dis 2007;34: S22-30.
37. MacDonald A, Benach J, Burgdorfer W. Stillbirth following maternal Lyme disease. N Y State J Med 1987;87:615-16.
38. Strobino BA, Williams CL, Abid S, Chalson R, Spierling P. Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am J Obstet Gynecol 1993;169:367-74.
39. Mhalu FS, Matre R. Serological evidence of Lyme borreliosis in Africa: results from studies in Dar Es Salaam, Tanzania. East Afr Med J 1996;73:583-85.
40. Melkert P W. Relapsing fever in pregnancy: analysis of high-risk factors. Br J Obstet Gynaecol 1988;95:1070-72.
41. Dupont HT, La Scola B, Williams R, Raoult D. A focus of tick-borne relapsing fever in southern Zaire. Clin Infect Dis 1997;25:139-44.
42. McConnell J. Tick-borne relapsing fever under-reported. Lancet Infect Dis 2003;3:604.
43. Jongen VH, van Roosmalen J, Tiems J, Van Holten J, Wetsteyn JC. Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet Gynecol Scand 1997;76:834-38.
44. Smith B, Kemp M, Ethelberg S, et al. Listeria monocytogenes: maternal-foetal infections in Denmark 1994-2005. Scand J Infect Dis 2009;41:21-25.
45. Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet 1994;44:119-24.
46. Pillay T, Sturm AW, Khan M, et al. Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int J Tuberc Lung Dis 2004;8:59-69.
47. Madan E, Meyer MP, Amortequi A. Chorioamnionitis: a study of organisms isolated in perinatal autopsies. Ann Clin Lab Sci 1988;18:39-45.
48. Blackwell S, Romero R, Chaiworapongsa T, et al. Maternal and fetal infl ammatory responses in unexplained fetal death. J Matern Fetal Neonatal Med 2003;14:151-57.
49. Romero R, Gomez R, Ghezzi F, et al. A fetal systemic infl ammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-93.
50. Lahra MM, Gordon A, Jeffery HE. Chorioamnionitis and fetal response in stillbirth. Am J Obstet Gynecol 2007;196: e1-4.
51. Folgosa E, Gonzalez C, Osman NB, Hagerstrand I, Bergstrom S, Ljungh A. A case control study of chorioamniotic infection and histological chorioamnionitis in stillbirth. APMIS 1997;105:329-36.
52. Tolockiene E, Morsing E, Holst E, et al. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand 2001;80:511-18.
53. Moyo SR, Hagerstrand I, Nystrom L, et al. Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological fi ndings. Int J Gynaecol Obstet 1996;54:115-23.
54. Moyo SR, Tswana SA, Nystrom L, Bergstrom S, Blomberg J, Ljungh A. Intrauterine death and infections during pregnancy. Int J Gynaecol Obstet 1995;51:211-18.
55. Axemo P, Ching C, Machungo F, Osman NB, Bergstrom S. Intrauterine infections and their association with stillbirth and preterm birth in Maputo, Mozambique. Gynecol Obstet Invest 1993;35:108-13.
56. Naeye RL, Tafari N, Judge D, Gilmour D, Marboe C. Amniotic fluid infections in an African city. J Pediatr 1977;90:965-70.
57. Goldenberg RL, Mudenda V, Read JS, et al, for the HPTN 024 Study Team. HPTN 024 study: histologic chorioamnionitis, antibiotics and adverse infant outcomes in a predominantly HIV-1-infected African population. Am J Obstet Gynecol 2006;195:1065-74.
58. Lamont R. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth. BJOG 2003;110:71-75.
59. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003;2: CD001058.
60. Tuomala RE, Shapiro DE, Mofenson LM, et al. Antiretrival therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002;346:1863-70.
61. Olagbuji BN, Ezeanochie MC, Ande AB, Oboro VO. Obstetric and perinatal outcome in HIV positive women receiving HAART in urban Nigeria. Arch Gynecol Obstet 2009; published online July 24. DOI:10.1007/s0040-009-1186-x.
62. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998;105:836-48.
63. Cutts F T, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, 1: burden of disease from CRS. Bull World Health Organ 1997;75:55-68.
64. Gershon AA. Chickenpox, measles and mumps. In: Remington JS, Klein JO, Baker C, Wilson CB, eds. Infectious diseases of fetus and newborn infant. Philadelphia, PA: WB Saunders, 2006:693-738.
65. Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol 2006;21:446-57.
66. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 1941;3:35-46.
67. Dayan GH, Zimmerman L, Shteinke L, et al. Investigation of a rubella outbreak in Kyrgyzstan in 2001: implications for an integrated approach to measles elimination and prevention of congenital rubella syndrome. J Infect Dis 2003;187 (suppl 1): S235-40.
68. Aaby P, Lisse IM, Bukh J, Seim E, de Silva MC. Increased perinatal mortality among children of mothers exposed to measles during pregnancy. Lancet 1988;331:516-19.
69. Stanwell-Smith R, Parker AM, Chakraverty P, Soltanpoor N, Simpson CN. Possible association of infl uenza A with fetal loss: investigation of a cluster of spontaneous abortions and stillbirths. Commun Dis Rep CDR Rev 1994;4: R28-32.
70. Ng WF, Wong SF, Lam A, et al. The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation. Pathology 2006;38:210-18.
71. Jamieson DJ, Honein MA, Rasmussen SA, et al, and the Novel Infl uenza A (H1N1) Pregnancy Working Group. H1N1 2009 infl uenza virus infection during pregnancy in the USA. Lancet 2009;374:451-58.
72. ACOG Committee on Obstetric Practice. ACOG committee opinion number 305, November 2004. Infl uenza vaccination and treatment during pregnancy. Obstet Gynecol 2004;104:1125-26.
73. Riipinen A, Väisänen E, Nuutila M, et al. Parvovirus b19 infection in fetal deaths. Clin Infect Dis 2008;47:1519-25.
74. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990;300:1166-70.
75. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105:174-78.
76. Tolfvenstam T, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection in intrauterine fetal death. Lancet 2001;357:1494-97.
77. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: a prospective evaluation of 1018 cases. Prenat Diagn 2004;24:513-18.
78. Wright, C, Hinchliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol 1996;103:133-36.
79. Kinney JS, Anderson LT, Farrar J, Strikas RA, Kumar ML, Kliegman RM. Risk of adverse outcomes after parvovirus B19 infection. J Infect Dis 1988;157:663-67.
80. Frisk G, Diderholm H. Increased frequency of Coxsackie B virus IgM in women with spontaneous abortion. J Infect 1992;24:141-45.
81. Maruyama Y, Sameshima H, Kamitomo M, et al. Fetal manifestations and poor outcomes of congenital cytomegalovirus infections: possible candidates for intrauterine antiviral treatments. J Obstet Gynaecol Res 2007;33:619-23.
82. Tongsong T, Sukpan K, Wanapirak C, Phadungkiatwattna P. Fetal cytomegalovirus infection associated with cerebral hemorrhage, hydrops fetalis, and echogenic bowel: case report. Fetal Diagn Ther 2008;23:169-72.
83. Howard J, Hall B, Brennan LE, et al. Utility of newborn screening cards for detecting CMV infection in cases of stillbirth. J Clin Virol 2009;44:215-18.
84. Syridou G, Spanakis N, Konstantinidou A, et al. Detection of cytomegalovirus, parvovirus B19 and herpes simplex viruses in cases of intrauterine fetal death: association with pathological fi ndings. J Med Virol 2008;80:1776-82.
85. Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. J Med Virol 2008;80:1747-48.
86. Hay SI, Guerra CA, Gething PW, et al. A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 2009;6: e1000048.
87. Skeketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med 2001;64:28-35.
88. Desai M, Oter Kuile F, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007;7:93-104.
89. McGregor IA, Wilson ME, Billewicz WZ. Malaria infection of the placenta in The Gambia, West Africa: its incidence and relationship to stillbirth, birth weight, and placenta weight. Trans R Soc Trop Med Hyg 1983;77:232-44.
90. Dorman EK, Shulman CE, Kingdom J, et al. Impaired uteroplacental blood fl ow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol 2002;19:165-70.
91. Van Geertruyden JP, Thomas F, Erhart A, D'Alessandro U. The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 2004;71 (suppl): 35-40.
92. Newman RD, Hailemariam A, Jimma D, et al. Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a non-epidemic year. J Infect Dis 2003;187:1765-72.
93. Oladapo OT, Adekanle DA, Durajaiye BO. Maternal risk factors associated with fetal death during antenatal care in low-resource tertiary hospitals. Aust NZJ Obstet Gynaecol 2007;47:383-88.
94. Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg 2007;77:69-78.
95. Coll O, Menedez C, Botet F, Dayal R, WAPM Perinatal Infections Working Group. Treatment and prevention of malaria in pregnancy and newborn. J Perinat Med 2008;36:15-29.
96. Okie S. A new attack on malaria. N Engl J Med 2008;358:2425-28.
97. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv 2001;56:296-305.
98. Onadeko MO, Joynson DH, Payne RA, Francis J. The prevalence of toxoplasma antibodies in pregnant Nigerian women and the occurrence of stillbirth and congenital malformation. Afr J Med Med Sci 1996;25:331-34.
99. Nimri L, Pelloux H, Elkhatib L. Detection of Toxoplasma gondii DNA and specifi c antibodies in high-risk pregnant women. Am J Trop Med Hyg 2004;71:831-35.
100. Lingam S, Marshall WC, Wilson J, Gould JM, Reinhardt MC, Evans DA. Congenital trypanosomiasis in a child born in London. Dev Med Child Neurol 1985;27:664-74.
101. Buekens P, Almendares O, Carlier Y, et al. Mother-to-child transmission of Chagas' disease in North America: why don't we do more? Matern Child Health J 2008;12:283-86.
102. de Silva NR, Sirisena JLGJ, Gunasekera DPS, Ismail MM, de Silva HJ. Effect of mebendazole therapy during pregnancy on birth outcome. Lancet 1999;353:1145-49.
103. Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005;105:857-68.
104. Gibbs RS, Roberts DJ. Case records of the Massachusetts General Hospital. Case 27-2007: a 30-year-old pregnant woman with intrauterine fetal death. N Engl J Med 2007;357:918-25.
105. Colbourn T, Asseburg C, Bojke L, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-eff ectiveness and expected value of information analyses. Health Technol Assess 2007;11:1-226.
106. DiGiulio D, Romero R, Amogan HP, et al. Microbial prevalence, diversity and abundance in amniotic fl uid during preterm labor: a molecular and culture-based investigation. PLoS One 2008;3: E3056.
107. Bhutta ZA, Darmstadt GL, Hasan BS, Haws RA. Community-based interventions for improving perinatal and neonatal health outcomes in developing countries: a review of the evidence. Pediatrics 2005;115 (suppl): 519-617.